Заключение

Таким образом, мы рассмотрели имеющиеся в современной литературе данные о нарушении функций периферических возбудимых структур при НДЗ. Проведенный анализ показал, что практически все наиболее распространенные НДЗ сопровождаются периферическими дисфункциями на уровне нервно-мышечного аппарата и/или сердечно-сосудистой системы.

Литература

Мухамедьяров М.А., Волков Е.М., Леушина А.В. и др. Ионные и молекулярные механизмы деполяризации скелетных мышечных волокон мыши под действием Р-амилоидного пептида // Росс. физиол. журнал им. И.М. Сеченова. 2011. Т 97. С. 795-803.

Мухамедьяров М.А., Зефиров А.Л. Влияние Р-амилоидного пептида на функции возбудимых тканей: физиологические и патологические аспекты // Успехи физиологических наук. 2013. Т 44. С. 5571.

Угрюмов М.В. Новые представления о патогенезе, диагностике и лечении нейродегенеративных заболеваний // Вестник РАМН, 2010. Т 8. С. 6-19.

Asai H., Hirano M., Udaka F. et al. Sympathetic disturbances increase risk of sudden cardiac arrest in sporadic ALS // J. Neurol. Sci. 2007. Vol.

Bunch T.J., Weiss J.P., CrandallB.G., et al. Atrial fibrillation is independently associated with senile, vascular, and Alzheimer’s dementia // Heart Rhythm. 2010. Vol. 7. P 433-437.

Caccamo A., Oddo S., Sugarman M.C. et al. Age- and region-dependent alterations in Abeta-degrading enzymes: implications for Abeta-induced disorders // Neurobiol. Aging. 2005. Vol. 26. P 645-654.

Carnevale D., Mascio G., DAndrea I. et al. Hypertension induces brain beta-amyloid accumulation, cognitive impairment, and memory deterioration through activation of receptor for advanced glycation end products in brain vasculature // Hypertension. 2012. Vol. 60. P. 188-197.

Chida K., Sakamaki S., Takasu T. Alteration in autonomic function and cardiovascular regulation in amyotrophic lateral sclerosis // J. Neurol. 1989. Vol. 236. P. 127-130.

Corcia P., Pradat P. F., Salachas F. et al. Causes of death in a post-mortem series of ALS patients // Amyo- troph. Lateral. Scler. 2008. Vol. 9. P. 59-62.

Crouch P.J., Harding S.M., White A.R. et al. Mechanisms of A beta mediated neurodegeneration in Alzheimer’s disease // Int. J. Biochem. Cell. Biol. 2008. Vol. 40. P. 181-198.

De la Torre J.C. Vascular risk factor detection and control may prevent Alzheimer’s disease // Ageing. Res. Rev. 2010. Vol. 9. P 218-225.

De Toledo Ferraz Alves T.C., Ferreira L.K., Wajngarten M. et al. Cardiac disorders as risk factors for Alzheimer’s disease // J. Alzheimers Dis. 2010. Vol. 20. P 749-763.

Dolan H., Crain B., Troncoso J. et al. Atherosclerosis, dementia, and Alzheimer disease in the Baltimore Longitudinal Study of Aging cohort // Ann. Neurol. 2010. Vol. 68. P. 231-240.

Druschky A., Spitzer A., Platsch G. et al. Cardiac sympathetic denervation in early stages of amyotrophic lateral sclerosis demonstrated by 123I-MIBG-SPECT // Acta. Neurol. Scand. 1999. Vol. 99. P. 308-314.

Dupuis L., Loeffler J.P. Neuromuscular junction destruction during amyotrophic lateral sclerosis: insights from transgenic models // Curr.

Garden G.A., La Spada A.R. Intercellular (mis)communication in neurodegenerative disease // Neuron. 2012. Vol. 73. P. 886-901.

Gdynia H.J., Kurt A., Endruhn S. et al. Cardiomyopathy in motor neuron diseases // J. Neurol. Neurosurg. Psychiatry. 2006. Vol. 77. P. 671-673.

Gil J., Funalot B., Verschueren A. et al. Causes of death amongst French patients with amyotrophic lateral sclerosis: a prospective study // Eur. J. Neurol. 2008. Vol. 15. P. 1245-1251.

Goldman W.P., Baty J.D., Buckles V.D. et al. Motor dysfunction in mildly demented AD individuals without extrapyramidal signs // Neurology. 1999. Vol. 53. P. 956-962.

Jefferson A.L., Himali J J., Beiser A.S. et al. Cardiac index is associated with brain aging: the Framingham Heart Study // Circulation. 2010. Vol. 122. P. 690-697.

Joachim C.L., Mori H., Selkoe D.J. Amyloid beta-protein deposition in tissues other than brain in Alzheimer’s disease // Nature. 1989. Vol. 341. P. 226-230.

Kamenetz F., Tomita T., Hsieh H., et al. APP processing and synaptic function // Neuron. 2003. Vol. 37. P. 925-937.

Kehoe P., Krawczak M., Harper P.S. et al. Age of onset in Huntington disease: sex specific influence of apolipoprotein E genotype and normal CAG repeat length // J. Med. Genet. 1999. Vol. 36. P. 108-111.

Kieburtz K., MacDonald M., Shih C. et al. Trinucleotide repeat length and progression of illness in Huntington’s disease // J. Med. Genet. 1994. Vol. 31. P. 872-874.

Kitazawa M., Green K.N., Caccamo A. et al. Genetically augmenting Abeta42 levels in skeletal muscle exacerbates inclusion body myositis-like pathology and motor deficits in transgenic mice // Am. J. Pathol. 2006. Vol. 168. P. 1986-1997.

Love S., Miners S., Palmer J. et al. Insights into the pathogenesis and pathogenicity of cerebral amyloid angiopathy // Frontiers in Bioscience. 2009. Vol. 14. P. 4778-4792.

Mehta P.D., Pirttila T., Mehta S.P. et al. Plasma and cerebrospinal fluid levels of amyloid beta proteins 1-40 and 1-42 in Alzheimer disease // Arch.

Mihm M.J., Amann D.M., Schanbacher B.L. et al. Cardiac dysfunction in the R6/2 mouse model of Huntington’s disease // Neurobiol. Dis. 2007. Vol. 25. P. 297-308.

Mukhamedyarov M.A., Grishin S.N., Yusupova E.R. et al. Alzheimer’s beta-amyloid-induced depolarization of skeletal muscle fibers: implications for motor dysfunctions in dementia // Cell. Physiol. Biochem. 2009. Vol. 23. P. 109-114.

Mukhamedyarov M.A., Teplov A.Y., Grishin S.N. et al. Extraneuronal toxicity of Alzheimer’s beta-amyloid peptide: comparative study on vertebrate skeletal muscles // Muscle and Nerve. 2011. Vol. 43. P. 872877.

Mukhamedyarov M.A., Volkov E.M., Khaliullina D.F. et al. Impaired electro-genesis in skeletal muscle fibers of transgenic Alzheimer mice // Neurochem. Int. 2014. Vol. 64. P. 24-28.

Murata Y., Harada T., Ishizaki F. et al. An abnormal relationship between blood pressure and pulse rate in amyotrophic lateral sclerosis // Acta. Neurol. Scand. 1997. Vol. 96. P. 118-122.

Palotas A., Reis H.J., Bogats G. et al. Coronary artery bypass surgery provokes Alzheimer’s disease-like changes in the cerebrospinal fluid // J. Alzheimers Dis. 2010. Vol. 21. P. 1153-1164.

Paris D., Patel N., DelleDonne A. et al. Impaired angiogenesis in a transgenic mouse model of cerebral amyloidosis // Neurosci. Lett. 2004. Vol. 366. P. 80-85.

Poehlman E.T., DvorakR.V Energy expenditure, energy intake, and weight loss in Alzheimer disease // Am. J. Clin. Nutr 2000. Vol. 71. P. 650S-655S.

Querfurth H.W., LaFerla F.M. Alzheimer’s disease // N. Engl. J. Med. 2010. Vol. 362. P. 329-344.

Reis H.J., Wang L., Verano-Braga T. et al. Evaluation of Post-Surgical Cognitive Function and Protein Fingerprints in the Cerebro-Spinal Fluid Utilizing Surface-Enhanced Laser Desorption/Ionization Time- of-Flight Mass-Spectrometry (SELDI-TOF MS) After Coronary Artery Bypass Grafting: Review of Proteomic Analytic Tools and Introducing a New Syndrome // Curr. Med. Chem.

RosendorffC., Beeri M.S., Silverman J.M. Cardiovascular risk factors for Alzheimer’s disease // Am. J. Geri- atr. Cardiol. 2007. Vol. 16. P. 143-149.

Rozas J.L., Gomez-Sanchez L., Tomas-Zapico C. et al. Increased neurotransmitter release at the neuromuscular junction in a mouse model of polyglutamine disease // J. Neurosci. 2011. Vol. 31. P. 1106-1113.

Sassone J., Colciago C., Cislaghi G. et al. Huntington’s disease: the current state of research with peripheral tissues // Exp. Neurol. 2009. Vol. 219. P. 385-397.

Scheibel A.B., Duong T.H., Jacobs R. Alzheimer’s disease as a capillary dementia // Ann. Med. 1989. Vol. 21. P. 103-107.

Selkoe D.J. Alzheimer’s disease is a synaptic failure // Science. 2002. Vol. 298. P. 789-791.

Selkoe D.J., Podlisny M.B., Joachim C.L. et al. Beta-amyloid precursor protein of Alzheimer disease occurs as 110- to 135-kilodalton membrane-associated proteins in neural and nonneural tissues // Proc. Natl. Acad. Sci. USA. 1988. Vol. 85. P. 7341-7345.

Skoog I., Lernfelt B., Landahl S. et al. 15-year longitudinal study of blood pressure and dementia // Lancet. 1996. Vol. 347. P. 1141-1145.

Soininen H., Syrjanen S., Heinonen O. et al. Amyloid beta-protein deposition in skin of patients with dementia // Lancet. 1992. Vol. 339. P. 245.

Spataro R., Lo Re M., Piccoli T. et al. Causes and place of death in Italian patients with amyotrophic lateral sclerosis // Acta. Neurol. Scand. 2010. Vol. 122. P. 217-223.

Tian J., Shi J., Mann D.M. Cerebral amyloid angiopathy and dementia // Panminerva. Med. 2004. Vol. 46. P. 253-264.

Turdi S., Guo R., HuffA.F. et al. Cardiomyocyte contractile dysfunction in the APPswe/PS1dE9 mouse model of Alzheimer’s disease // PLoS One. 2009. Vol. 4. P. e6033.

Van Nostrand W.E., Melchor J.P., Ruffini L. Pathologic amyloid beta-protein cell surface fibril assembly on cultured human cerebrovascular smooth muscle cells // J. Neurochem. 1998. Vol. 70. P. 216-223.

Wirths O., Bayer T.A. Motor impairment in Alzheimer’s disease and transgenic Alzheimer’s disease mouse models // Genes Brain Behav. 2008. Vol. 7. Suppl. 1. P. 1-5.

Zamolodchikov D., Strickland S. Abeta delays fibrin clot lysis by altering fibrin structure and attenuating plasminogen binding to fibrin // Blood. 2012. Vol. 119. P. 3342-3351.